Elevance Health, Inc.
ELV
$376.63
$13.893.83%
NYSE
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 41.79B | 41.18B | 42.42B | 41.76B | 41.48B |
| Total Other Revenue | 8.39B | 8.57B | 8.30B | 8.02B | 7.41B |
| Total Revenue | 50.18B | 49.75B | 50.71B | 49.78B | 48.89B |
| Cost of Revenue | 35.62B | 38.07B | 38.14B | 36.71B | 35.31B |
| Gross Profit | 14.57B | 11.68B | 12.57B | 13.07B | 13.58B |
| SG&A Expenses | 11.79B | 10.75B | 10.65B | 10.29B | 10.28B |
| Depreciation & Amortization | 112.00M | 164.00M | 162.00M | 147.00M | 155.00M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 47.52B | 48.98B | 48.95B | 47.14B | 45.75B |
| Operating Income | 2.66B | 766.00M | 1.76B | 2.63B | 3.14B |
| Income Before Tax | 2.30B | 215.00M | 1.41B | 2.29B | 2.80B |
| Income Tax Expenses | 544.00M | -331.00M | 219.00M | 548.00M | 613.00M |
| Earnings from Continuing Operations | 1.76B | 546.00M | 1.19B | 1.74B | 2.18B |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 4.00M | 1.00M | 2.00M | -1.00M | -1.00M |
| Net Income | 1.76B | 547.00M | 1.19B | 1.74B | 2.18B |
| EBIT | 2.66B | 766.00M | 1.76B | 2.63B | 3.14B |
| EBITDA | 3.02B | 1.17B | 2.14B | 3.01B | 3.51B |
| EPS Basic | 8.03 | 2.47 | 5.32 | 7.74 | 9.64 |
| Normalized Basic EPS | 6.57 | 1.13 | 3.94 | 6.36 | 7.72 |
| EPS Diluted | 8.00 | 2.47 | 5.32 | 7.72 | 9.61 |
| Normalized Diluted EPS | 6.55 | 1.13 | 3.94 | 6.34 | 7.69 |
| Average Basic Shares Outstanding | 219.80M | 221.80M | 223.30M | 225.20M | 226.40M |
| Average Diluted Shares Outstanding | 220.40M | 221.80M | 223.70M | 225.80M | 227.20M |
| Dividend Per Share | 1.72 | 1.71 | 1.71 | 1.71 | 1.71 |
| Payout Ratio | 21.32% | 68.92% | 32.04% | 22.09% | 17.68% |